Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zoetis Inc (NYSE:ZTS)

50.26
Delayed Data
As of Jul 22
 +0.12 / +0.24%
Today’s Change
37.73
Today|||52-Week Range
50.39
+4.88%
Year-to-Date
Nutrisystem (NTRI) Q2 Earnings: What's in the Cards?
Jul 22 / Zacks.com - Paid Partner Content
Jim Cramer's Top Takeaways: Zoetis, Idexx, Danaher, Fortive
Jul 20 / TheStreet.com - Paid Partner Content
C.R. Bard (BCR) Well Poised to Beat Q2 Earnings Estimates?
Jul 21 / Zacks.com - Paid Partner Content
Bill Ackman's Portfolio Returns Diminish as Stock Prices Decline
Jul 19 / GuruFocus News - Paid Partner Content
Baxter International (BAX) Q2 Earnings: What's in Store?
Jul 21 / Zacks.com - Paid Partner Content
5 Stocks with High ROE to Buy as Earnings Bells Chime
Jul 19 / Zacks.com - Paid Partner Content
Can CryoLife (CRY) Earnings Spring a Surprise in Q2?
Jul 21 / Zacks.com - Paid Partner Content
Can Zoetis (ZTS) Keep the Earnings Streak Alive This Quarter?
Jul 19 / Zacks.com - Paid Partner Content
Zacks.com featured highlights: Altria Group, Priceline Group, Zoetis, Gilead Sciences...
Jul 20 / Zacks.com - Paid Partner Content
Analyst: Merck's Fundamentals Don't Warrant Current Valuation
Jul 18 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close50.14
Today’s open50.17
Day’s range49.87 - 50.36
Volume1,308,113
Average volume (3 months)3,708,034
Market cap$24.9B
Dividend yield0.76%
Data as of 4:04pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-41.38%
Earnings growth (this year)+5.48%
Earnings growth (next 5 years)+15.40%
Revenue growth (last year)-0.42%
P/E ratio66.6
Price/Sales5.05
Price/Book23.41

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV-0.27-0.58%
VRTXVertex Pharmaceutica...+0.68+0.73%
ALXNAlexion Pharmaceutic...-1.50-1.18%
INCYIncyte Corp-1.38-1.57%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$0.44
Annual revenue (last year)$4.8B
Annual profit (last year)$339.0M
Net profit margin7.11%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
Florham Park, New Jersey

Forecasts

Partner Offers

Search for Jobs